Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (5836)	1/3/1999 11:49:00 PM
From: tommysdad	Read Replies (1) \| Respond to of 6136

Umm, Izzy, you're forgetting how many shares there are. DD is worth twenty times AGPH -- AGPH has a market cap of about $1.9 billion, DD about $58 billion. Yeah, DD could swallow AGPH whole, and probably pay cash for it. They got a bunch of cash from Merck when DuMPCo (DuPont-Merck Pharmaceutical Company) became part of DuPont again. They might want MTC too, mainly to get Celebrex -- the MTC/AHP fell through, so why not DD? DD has a big stake in Ag products and that is probably MTC's strength. Might get the "monopoly police" on their tail, though. I still like DD buying AGPH -- but I'm not sure the research arm of DuPont Pharma would meld well with AGPH's research department. I know too many people at both places, and they just don't seem to have similar approaches to how they go about business. Could be ugly, from that perspective.

To: Izzy who wrote (5836)	1/4/1999 3:02:00 AM
From: FNS	Respond to of 6136

Issy: Re <<look at the posts on Yahoo DD/MTC BBs. Several seem to think that DD will buyout MTC (apparently a long-standing rumor but appears to be more imminent now).>> Can't comment intelligently on the rumors. Looks like DD is super buy if you can buy it near where it closed on Thursday...little risk with upside potential. MTC bothers me by selling off from the high of 50 ( near resistance level)...should move higher on the good news but perhaps the stock has discounted this somewhat. Note that PFE is also a co-promoter of celebrex. You may have already seen: 12/31 14:05 *MONSANTO [MTC-news] SAYS GETS LETTER OF APPROVAL FROM FDA FOR CELEBREX CHICAGO, Dec 31 (Reuters) - Life sciences firm Monsanto Co. [MTC-news] said on Thursday the U.S. Food and Drug Administration approved its Celebrex drug to treat rheumatoid arthritis and osteoarthritis, which affect about 16 million Americans. Celebrex is the first in a new class of drugs known as COX-2 inhibitors. They are designed to work as well as other analgesics such as aspirin, ibuprofen and naproxen, but without potentially fatal side effects. Analysts have said the market for Celebrex is huge, with potential sales of $1 billion in the first year in the United States alone. ..................... (However, I recall reading that if you're allergic to aspirin you shouldn't take celebrex!) Am still long AGPH and am planning to add on a pull back to mid 50's. (Off topic: Take a look at CNTO and CHIR if the bio's interest you.) FNS